Acute Myeloid Leukemia Clinical Trial

Home Away From Home – Medical Outcomes

Summary

Treatment for pediatric acute myeloid leukemia (AML) involves intensive chemotherapy regimens that result in periods of profound neutropenia leaving patients susceptible to severe infectious complications. Infectious complications are the leading cause of treatment related mortality among AML patients, but there are little clinical data to inform whether management of neutropenia post AML chemotherapy should occur in an outpatient or inpatient setting. The primary objective of this study is to compare the clinical effectiveness of outpatient versus inpatient management of neutropenia in children with AML.

View Full Description

Full Description

This is a bidirectional observational cohort study.

Participants will be patients less that 19 years of age at diagnosis receiving or having received chemotherapy for AML from seventeen participating pediatric hospitals across the United States. There is no study intervention; this is a medical record abstraction study only. Investigators will abstract subjects medical record data over the study period in order to study clinical outcomes including the occurrence of bacteremia and time to the start of the next course in the chemotherapy regimen, in relation to neutropenia management strategy.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Males or females of age less than 19 at diagnosis.
Receipt or planned receipt of AML chemotherapy between January 1, 2012 and December 31, 2019.

Exclusion Criteria:

Patients being treated for relapsed AML
Patients with Acute Promyelocytic Leukemia (APML)
Patients undergoing stem cell transplant (SCT)
Patients receiving reduced intensity frontline chemotherapy

Study is for people with:

Acute Myeloid Leukemia

Estimated Enrollment:

610

Study ID:

NCT02774850

Recruitment Status:

Completed

Sponsor:

Children's Hospital of Philadelphia

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 17 Locations for this study

See Locations Near You

Arkansas Children's Hospital
Little Rock Arkansas, 72202, United States
Lucile Packard Children's Hospital
Palo Alto California, 94304, United States
Rady Children's Hospital
San Diego California, 92123, United States
Children's Hospital of Colorado
Aurora Colorado, 80045, United States
Alfred I DuPont Hospital for Children
Wilmington Delaware, 19803, United States
Children's Healthcare of Atlanta
Atlanta Georgia, 30329, United States
Ann & Robert H Lurie Children's Hospital
Chicago Illinois, 60611, United States
Ochsner Medical Center
New Orleans Louisiana, 70121, United States
Dana-Farber Cancer Institute/Boston Children's Hospital
Boston Massachusetts, 02215, United States
C.S. Mott Children's Hospital
Ann Arbor Michigan, 48109, United States
Children's Hospital of Michigan
Detroit Michigan, 48201, United States
University of Mississippi Medical Center
Jackson Mississippi, 39216, United States
Children's Hospital of Philadelphia
Philadelphia Pennsylvania, 19104, United States
Children's Medical Center of Dallas
Dallas Texas, 75235, United States
Texas Children's Hospital
Houston Texas, 77030, United States
Primary Children's Hospital
Salt Lake City Utah, 84132, United States
Seattle Children's Hospital
Seattle Washington, 98105, United States

How clear is this clinincal trial information?

Study is for people with:

Acute Myeloid Leukemia

Estimated Enrollment:

610

Study ID:

NCT02774850

Recruitment Status:

Completed

Sponsor:


Children's Hospital of Philadelphia

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider